Literature DB >> 1988773

Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells.

Y Hattori1, K Kasai, T Nakamura, T Emoto, S Shimoda.   

Abstract

We measured the release of immunoreactive endothelin-1 (IR-ET-1) by cultured porcine aortic endothelial cells under normoglycemic (5.5 mmol/L) and hyperglycemic (27.5 and 55 mmol/L) conditions. Compared with cells incubated in the presence of a normal glucose concentration, cells incubated in 27.5 mmol/L glucose medium released 52% less IR-ET-1, and those incubated in 55 mmol/L glucose medium released 54% less IR-ET-1. The observed effects of elevated glucose on IR-ET-1 release were both sugar-specific and not due to increased osmolarity. Fetal calf serum (FCS)-stimulated IR-ET-1 release in the presence of elevated glucose was also less than that in the presence of a normal glucose concentration. In addition, the effects of two hormones, insulin and insulin-like growth factor 1 (IGF-1), on IR-ET-1 release were examined. Both insulin and IGF-1 dose-dependently stimulated IR-ET-1 release. Twenty micrograms/mL insulin and 10(-8) mol/L IGF-1 increased IR-ET-1 release by 38% and by 44%, respectively. These results indicate that hyperglycemic condition results in reduction of IR-ET-1 release from cultured porcine aortic endothelial cells and that insulin and IGF-1 stimulate its release. The possible relevance of these observations to physiological regulation of ET-1 release in vivo and pathological processes in diabetes remains to be established.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988773     DOI: 10.1016/0026-0495(91)90168-v

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Endothelin-1 response to glucose and insulin among African Americans.

Authors:  Stephanie DeLoach; Yonghong Huan; Constantine Daskalakis; Bonita Falkner
Journal:  J Am Soc Hypertens       Date:  2010-08-21

Review 2.  Role of endothelin in diabetic vascular complications.

Authors:  H C Lam
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 3.  Endothelin: a new vasoactive ocular peptide.

Authors:  U Chakravarthy; D B Archer
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

4.  Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.

Authors:  Kamakshi Sachidanandam; Vera Portik-Dobos; Aisha I Kelly-Cobbs; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2010-06       Impact factor: 2.273

5.  Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients.

Authors:  F Perfetto; R Tarquini; V de Leonardis; A Piluso; V Lombardi; B Tarquini
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

6.  Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.

Authors:  Leryn J Reynolds; Daniel P Credeur; Camila Manrique; Jaume Padilla; Paul J Fadel; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2016-10-27

7.  Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

Authors:  Kamakshi Sachidanandam; Jim R Hutchinson; Mostafa M Elgebaly; Erin M Mezzetti; Anne M Dorrance; Kouros Motamed; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-28       Impact factor: 3.619

8.  Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone.

Authors:  M Trovati; P Massucco; L Mattiello; F Cavalot; E Mularoni; A Hahn; G Anfossi
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

9.  Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin-1 of aortic rings from streptozotocin-induced diabetic rats.

Authors:  W C Hodgson; R G King
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

10.  The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis.

Authors:  Bulent Degertekin; Seren Ozenirler; Sehri Elbeg; Gulen Akyol
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.